PTDSS2

Phosphatidylserine synthase 2 · Q9BVG9 · PTDSS2 on Sugi Atlas →

0 patent compounds predicted against PTDSS2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to PTDSS2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
AntiCoagulants and COGnition PHASE4UNKNOWN
99m Tc-ANNexin-V-128 Scintigraphy for the Identification of Complicated Carotid Atherosclerotic Plaques PHASE2/PHASE3WITHDRAWN
Lovaza's Effect on the Activation of Platelets PHASE2COMPLETED
The Nutritional Supplement Phosphatidylserine in Patients With Familial Dysautonomia PHASE2COMPLETED
Vitamin E and DHA-EE on NAFLD - Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial (PUVENAFLD) PHASE2COMPLETED
Hereditary Sensory Neuropathy Serine Trial PHASE2UNKNOWN
Anti-CD38 Antibody Treating APS With Thrombocytopenia PHASE2RECRUITING
Effect of Gemfibrozil on Serum Glycosylphosphatidylinositol (GPI) Phospholipase D and Triglycerides PHASE1COMPLETED
Efferocytosis and Genomic Polymorphism in Autoimmune Diseases nanUNKNOWN
Composition & Function of Sarcoplasmic Reticulum in Persons With the Metabolic Syndrome nanCOMPLETED
Structural Network on Prostate Cancer in the French Greater West Region nanCOMPLETED
Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis) nanCOMPLETED
Skeletal Muscle Diacylglycerol and Sphingolipids - Impact of Localization and Species on Insulin Resistance in Humans nanCOMPLETED
the Role of plin5 in the Development of Nonalcoholic Fatty Liver Disease. nanUNKNOWN
Evaluation of Plasma Sphingosine-1-Phosphate as A Diagnostic and Prognostic Biomarkers of Community-Acquired Pneumonia nanUNKNOWN
Oncometabolome and MALDI-MSI in Upper GI Carcinomas - Chemosensitivity in Esophageal Carcinoma nanACTIVE_NOT_RECRUITING
Duality of Lipids: the Athlete's Paradox nanCOMPLETED
Efficacy Study of Vayarin in Children With Autism and Comorbid Attention Deficit Hyperactivity Disorder (ADHD) nanCOMPLETED
Plaque Calcium Characterization and Ruptured Plaques nanUNKNOWN
Sphingo-lipotoxicity and Trans-differentiation of Adipose Tissue in Obesity (SFINGOTRANS) nanCOMPLETED
Canola Oil Multicentre Intervention Trial nanCOMPLETED
Development of Biomarker for Development of Non-Alcoholic Steatohepatitis (NASH) in Children nanWITHDRAWN
Epidemiology of Atherosclerosis nanCOMPLETED
Study of STIM1 Membrane Expression nanRECRUITING
Vulvodynia: Identification of Potential Relevant Biomarkers nanCOMPLETED
Epigenomic and Metabolomic Signatures of APOA2 Gene by Saturated Fat Interaction nanCOMPLETED
Screening of Healthy Adults for Genetic Variations That Control Fatty Acid Processing nanCOMPLETED
Lipidomic and Multi-Omics Profiling of Fatty Liver Disease in People With and Without HIV nanNOT_YET_RECRUITING
Open-Label Study of Omega 3 Oil Supplementation for Aging-Related Cognitive Decline nanCOMPLETED
Ceramide Level as Apredictor of Outcomes in Patients of Anterior Myocardial Infarction Undergoing Primary Coronary Intervention nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a PTDSS2 binder may also engage these)

ProteinNameSimilarity
O08888 0.993 O08888 →
E1BYA3 0.992 E1BYA3 →
Q9Z1X2 0.992 Q9Z1X2 →
B2GV22 0.991 B2GV22 →
Q08D11 0.990 Q08D11 →
E7EY42 0.990 E7EY42 →
P36380 0.982 P36380 →
Q9NTQ9 0.981 Q9NTQ9 →
D4AD75 0.980 D4AD75 →
Q7M734 0.980 Q7M734 →
P28231 0.979 P28231 →
Q9XT96 0.979 Q9XT96 →
Q5RCN9 0.979 Q5RCN9 →
Q58D78 0.979 Q58D78 →
Q18695 0.978 Q18695 →
A4IFL1 0.978 A4IFL1 →
Q0MS45 0.978 Q0MS45 →
Q8BI36 0.978 Q8BI36 →
Q6PEY0 0.977 Q6PEY0 →
Q03190 0.977 Q03190 →
P15920 0.977 P15920 →
PSEN2 Presenilin-2 0.977 landscape →
Q28FG4 0.976 Q28FG4 →
Q90ZE4 0.976 Q90ZE4 →
B2RXE2 0.976 B2RXE2 →
Q90830 0.976 Q90830 →
P51914 0.976 P51914 →
Q641M3 0.976 Q641M3 →
O88777 0.976 O88777 →
O95377 0.976 O95377 →